| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 3,476,900 | 3,195,400 | 3,625,900 | 3,101,400 | | Cost of Revenue | 1,898,600 | 2,844,600 | 2,537,400 | 2,248,500 | | | Gross Profit | 1,578,300 | 350,800 | 1,088,500 | 852,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,061,500 |
-
| 556,700 | 502,700 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 516,800 | 350,800 | 531,800 | 350,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,700 | 14,400 | 9,000 | 6,900 | | Earnings Before Interest And Taxes | 529,500 | 365,200 | 540,800 | 357,100 | | Interest Expense | 31,400 | 25,400 | 23,200 | 26,200 | | Income Before Tax | 498,100 | 339,800 | 517,600 | 330,900 | | Income Tax Expense | 167,200 | 115,200 | 175,500 | 112,100 | | Minority Interest | (35,000) | (24,000) | (40,900) | (24,700) | | | | Net Income From Continuing Ops | 306,900 | 208,700 | 313,800 | 202,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 306,900 | 208,700 | 313,800 | 202,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $306,900 | $208,700 | $313,800 | $202,200 |
|
1.49% Nasdaq 
0.27%
Income Statement
